Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Waste-Minimized Approach to Cassar-Heck Reaction Based on POLITAG-Pd0 Heterogeneous Catalyst and Recoverable Acetonitrile Azeotrope. | ChemSusChem | 2021 | 34240814 | PubTator, text mining | PubMed |
| Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1. | Nagoya J Med Sci | 2021 | 34239173 | PubTator, text mining | PubMed |
| How I treat stage II colon cancer patients. | ESMO Open | 2021 | 34237612 | PubTator, text mining | PubMed |
| Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil. | J Cancer | 2021 | 34234856 | PubTator, text mining | PubMed |
| Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism. | Drug Des Devel Ther | 2021 | 34234410 | PubTator, text mining | PubMed |
| Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious Medicine. | Clin Pharmacol Ther | 2021 | 34233023 | PubTator, text mining | PubMed |
| Increase in recruitment upon integration of trial into a clinical care pathway: an observational study. | BMJ Open Respir Res | 2021 | 34230034 | PubTator, text mining | PubMed |
| Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art. | Cancers (Basel) | 2021 | 34205656 | PubTator, text mining | PubMed |
| What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review. | Pharmaceuticals (Basel) | 2021 | 34204714 | PubTator, text mining | PubMed |
| ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC). | Cancers (Basel) | 2021 | 34201274 | PubTator, text mining | PubMed |
| Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation. | Adv Drug Deliv Rev | 2021 | 34192550 | PubTator, text mining | PubMed |
| Identification ACTA2 and KDR as key proteins for prognosis of PD-1/PD-L1 blockade therapy in melanoma. | Animal Model Exp Med | 2021 | 34179721 | PubTator, text mining | PubMed |
| EACPT Virtual Meeting 2021. | Eur J Clin Pharmacol | 2021 | 34173020 | PubTator, text mining | PubMed |
| TGF-β-dependent reprogramming of amino acid metabolism induces epithelial-mesenchymal transition in non-small cell lung cancers. | Commun Biol | 2021 | 34168290 | PubTator, text mining | PubMed |
| Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). | Pharmacogenet Genomics | 2021 | 34149004 | PubTator, text mining | PubMed |
| Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. | Adv Cancer Res | 2021 | 34148615 | PubTator, text mining | PubMed |
| Spatial and cell type transcriptional landscape of human cerebellar development. | Nat Neurosci | 2021 | 34140698 | PubTator, text mining | PubMed |
| Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease. | Sci Transl Med | 2021 | 34135108 | PubTator, text mining | PubMed |
| Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma. | Cancer Chemother Pharmacol | 2021 | 34132895 | PubTator, text mining | PubMed |
| Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men. | Front Cell Infect Microbiol | 2021 | 34123865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=60